MESA LABORATORIES INC /CO
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $249.1M | $241.0M | $216.2M | $219.1M | $184.3M | $133.9M | $117.7M | $103.1M |
| Cost of Revenue | $90.9M | $90.1M | $82.9M | $85.4M | $75.2M | $46.9M | $52.3M | $42.2M |
| Gross Profit | $158.3M | $150.9M | $133.3M | $133.7M | $109.1M | $87.0M | $65.4M | $60.9M |
| Gross Margin | 63.5% | 62.6% | 61.6% | 61.0% | 59.2% | 65.0% | 55.5% | 59.1% |
| Operating Expenses | ||||||||
| Research & Development | $20.3M | $19.5M | $19.3M | $20.5M | $15.8M | $10.4M | $6.4M | $3.5M |
| SG&A Expense | $78.7M | $73.3M | $72.9M | $72.4M | $60.3M | $45.8M | $38.2M | $31.3M |
| Operating Income | $18.5M | $16.3M | $-272.1M | $3.3M | $4.7M | $12.4M | $7.9M | $9.8M |
| Operating Margin | 7.4% | 6.8% | -125.9% | 1.5% | 2.6% | 9.2% | 6.7% | 9.5% |
| Interest Expense | — | — | $5.7M | $4.8M | $3.9M | $8.0M | $5.5M | $1.7M |
| Pretax Income | $12.0M | $6.0M | $-275.6M | $-389.0K | $3.6M | $2.3M | $3.9M | $8.6M |
| Income Tax Expense | $5.3M | $7.9M | $-21.4M | $-1.3M | $1.7M | $-971.0K | $2.1M | $1.1M |
| Net Income | $6.7M | $-2.0M | $-254.2M | $930.0K | $1.9M | $3.3M | $1.8M | $7.5M |
| Net Margin | 2.7% | -0.8% | -117.6% | 0.4% | 1.0% | 2.4% | 1.5% | 7.3% |
| EPS (Basic) | $1.22 | $-0.36 | $-47.20 | $0.17 | $0.36 | $0.66 | $0.42 | $1.95 |
| EPS (Diluted) | $1.21 | $-0.36 | $-47.20 | $0.17 | $0.35 | $0.64 | $0.41 | $1.86 |
| Shares Outstanding (Basic) | 5.5M | 5.4M | 5.4M | 5.3M | 5.2M | 5.0M | 4.2M | 3.8M |
| Shares Outstanding (Diluted) | 5.6M | 5.4M | 5.4M | 5.4M | 5.3M | 5.1M | 4.4M | 4.0M |
| Dividends Per Share | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 |